BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29169961)

  • 1. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release.
    Seillier A; Giuffrida A
    Neuropharmacology; 2018 Mar; 130():1-9. PubMed ID: 29169961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
    Spradley JM; Guindon J; Hohmann AG
    Pharmacol Res; 2010 Sep; 62(3):249-58. PubMed ID: 20416378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of fatty-acid amide hydrolase and CB1 receptor antagonism differentially affect behavioural responses in normal and PCP-treated rats.
    Seillier A; Advani T; Cassano T; Hensler JG; Giuffrida A
    Int J Neuropsychopharmacol; 2010 Apr; 13(3):373-86. PubMed ID: 19607756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S; Nomikos GG; Panagis G
    Psychopharmacology (Berl); 2006 Oct; 188(3):293-305. PubMed ID: 16953388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A role for vanilloid receptor 1 (TRPV1) and endocannabinnoid signalling in the regulation of spontaneous and L-DOPA induced locomotion in normal and reserpine-treated rats.
    Lee J; Di Marzo V; Brotchie JM
    Neuropharmacology; 2006 Sep; 51(3):557-65. PubMed ID: 16806299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of the endocannabinoid system in retinal damage after high intraocular pressure-induced ischemia in rats.
    Nucci C; Gasperi V; Tartaglione R; Cerulli A; Terrinoni A; Bari M; De Simone C; Agrò AF; Morrone LA; Corasaniti MT; Bagetta G; Maccarrone M
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):2997-3004. PubMed ID: 17591864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
    Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
    J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice.
    Naderi N; Aziz Ahari F; Shafaghi B; Najarkolaei AH; Motamedi F
    J Neural Transm (Vienna); 2008 Nov; 115(11):1501-11. PubMed ID: 18575801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus.
    Soria-Gómez E; Matias I; Rueda-Orozco PE; Cisneros M; Petrosino S; Navarro L; Di Marzo V; Prospéro-García O
    Br J Pharmacol; 2007 Aug; 151(7):1109-16. PubMed ID: 17549045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters.
    Moise AM; Eisenstein SA; Astarita G; Piomelli D; Hohmann AG
    Psychopharmacology (Berl); 2008 Oct; 200(3):333-46. PubMed ID: 18545985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocannabinoid-mediated enhancement of fear-conditioned analgesia in rats: opioid receptor dependency and molecular correlates.
    Butler RK; Rea K; Lang Y; Gavin AM; Finn DP
    Pain; 2008 Dec; 140(3):491-500. PubMed ID: 19004548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the basolateral nucleus of the amygdala in endocannabinoid-mediated stress-induced analgesia.
    Connell K; Bolton N; Olsen D; Piomelli D; Hohmann AG
    Neurosci Lett; 2006 Apr; 397(3):180-4. PubMed ID: 16378681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat.
    Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R
    Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoid modulation of male rat sexual behavior.
    Gorzalka BB; Morrish AC; Hill MN
    Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors.
    Moreira FA; Kaiser N; Monory K; Lutz B
    Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CB1 receptor-mediated control of the release of endocannabinoids (as assessed by microdialysis coupled with LC/MS) in the rat hypothalamus.
    Béquet F; Uzabiaga F; Desbazeille M; Ludwiczak P; Maftouh M; Picard C; Scatton B; Le Fur G
    Eur J Neurosci; 2007 Dec; 26(12):3458-64. PubMed ID: 18052990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1,3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) Enhances retrograde endocannabinoid signaling.
    Pan B; Wang W; Long JZ; Sun D; Hillard CJ; Cravatt BF; Liu QS
    J Pharmacol Exp Ther; 2009 Nov; 331(2):591-7. PubMed ID: 19666749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between cannabinoid compounds and diazepam on anxiety-like behaviour of mice.
    Naderi N; Haghparast A; Saber-Tehrani A; Rezaii N; Alizadeh AM; Khani A; Motamedi F
    Pharmacol Biochem Behav; 2008 Mar; 89(1):64-75. PubMed ID: 18096213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats.
    Seillier A; Giuffrida A
    Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.